healthŌme and GalenusRx Forge Strategic Partnership to Launch Genomics-based Personalized Medication Safety Program

Mitigating Risk with Personalized, Precision Medication Safety

June 12, 2025 10:30 am

Overview

You’re invited to a special webinar hosted by Hannover Re for key partners. Chris Arvia will be joined by Dr. Jacques Turgeon for a discussion on how to proactively identify and mitigate medication-related risk using personalized, data-driven insights. The session will include a live audience Q&A.

dates and location

Timezone: Central
Speakers

Jacques Turgeon, PhD, BPharm
Founder, Co-CEO, & Chief Scientific Officer GalenusRx

Chris Arvia
Vice President, Health Solutions Hannover Re